Izuforant
N/A
Report date: 2023/08/31 09:42:45
NME
Base Information
Drug NameIzuforant
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[11]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJw Pharmaceutical Corp
China Registration ClassN/A
Develop Information
Active CompaniesJw Pharmaceutical CorpLeo Pharma Consultancy(Shanghai)Company LtdLeo Pharma Inc +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A